Zacks Research Upgrades Acadia Healthcare (NASDAQ:ACHC) to Hold

Acadia Healthcare (NASDAQ:ACHC) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Thursday,Zacks.com reports.

A number of other equities research analysts have also recently issued reports on ACHC. Guggenheim dropped their target price on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a report on Monday, February 23rd. Royal Bank Of Canada boosted their price target on Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, February 26th. Raymond James Financial restated an “outperform” rating and issued a $25.00 price objective on shares of Acadia Healthcare in a research note on Thursday, February 26th. KeyCorp reduced their target price on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, December 3rd. Finally, Bank of America lowered Acadia Healthcare from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $21.50 to $13.00 in a report on Wednesday, December 3rd. Seven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $21.15.

Acadia Healthcare Trading Up 3.9%

Shares of Acadia Healthcare stock opened at $25.62 on Thursday. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $31.43. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 1.27. The business’s 50 day moving average is $15.80 and its 200-day moving average is $18.69. The stock has a market cap of $2.36 billion, a P/E ratio of -2.10, a P/E/G ratio of 8.33 and a beta of 0.74.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. The business had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.64 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Equities research analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Acadia Healthcare during the first quarter worth $1,600,000. Goldman Sachs Group Inc. raised its position in Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after purchasing an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after buying an additional 27,207 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in shares of Acadia Healthcare by 54.2% in the second quarter. Envestnet Asset Management Inc. now owns 166,880 shares of the company’s stock valued at $3,786,000 after buying an additional 58,642 shares during the period. Finally, Campbell & CO Investment Adviser LLC lifted its stake in shares of Acadia Healthcare by 119.0% in the second quarter. Campbell & CO Investment Adviser LLC now owns 74,717 shares of the company’s stock worth $1,695,000 after acquiring an additional 40,592 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.